Contact Us
Drug Search Results
More Filters [+]

Sodium stibogluconate

Alternative Names: sodium stibogluconate
Latest Update: 2024-12-05
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | China | Jordan | Malta | Pakistan | Peru | Saudi Arabia | Slovenia | Sri Lanka | Turkey | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Drugs for Neglected Diseases
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sodium stibogluconate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Leishmaniasis, Visceral

Phase 2: Renal Cell Carcinoma|Melanoma|Skin Cancer|Leishmaniasis|Myelodysplastic Syndrome|Leishmaniasis, Visceral|Leishmaniasis, Cutaneous|Preleukemia|Acute Myeloid Leukemia

Phase 1: Melanoma|Sarcoma|Myelodysplastic Syndrome|Kidney Diseases|Lymphoma|Preleukemia|Kidney Cancer|Renal Cell Carcinoma|Skin Cancer|Large Cell Carcinoma|NUT Carcinoma|Soft Tissue Cancer|Small Cell Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ImmStat@Cure (PK202001)

N/A

Active, not recruiting

Leishmaniasis, Visceral

2024-09-30

FirstJinanU_SSG

P2

Unknown status

Preleukemia|Myelodysplastic Syndrome|Acute Myeloid Leukemia

2023-02-01

NU 08H4

P1

Terminated

Preleukemia|Myelodysplastic Syndrome

2012-03-01

LEAP 0208

P2

Completed

Leishmaniasis, Visceral

2011-06-01

Recent News Events

Date

Type

Title

05/11/2024

PubMed

 In Vivo Bioluminescence Imaging Reveals Differences in Leishmania infantum Parasite Killing Kinetics by Antileishmanial Reference Drugs.

05/07/2024

PubMed

 Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.

04/29/2024

PubMed

 Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions